131 related articles for article (PubMed ID: 16622640)
1. [Phosphate in ophthalmologic solutions].
Bernauer W; Thiel MA; Rentsch KM
Ophthalmologe; 2006 May; 103(5):416-7. PubMed ID: 16622640
[No Abstract] [Full Text] [Related]
2. Corneal calcification after chemical eye burns caused by eye drops containing phosphate buffer.
Brandslund I; Damgaard AL
Burns; 2008 Dec; 34(8):1215. PubMed ID: 18674864
[No Abstract] [Full Text] [Related]
3. Corneal calcification after chemical eye burns caused by eye drops containing phosphate buffer.
Kompa S; Redbrake C; Dunkel B; Weber A; Schrage N
Burns; 2006 Sep; 32(6):744-7. PubMed ID: 16835011
[TBL] [Abstract][Full Text] [Related]
4. Phosphate-containing eye drops: corneal opacity.
Prescrire Int; 2013 Jun; 22(139):154. PubMed ID: 23866353
[TBL] [Abstract][Full Text] [Related]
5. Corneal calcification and phosphates: do you need to prescribe phosphate free?
Popiela MZ; Hawksworth N
J Ocul Pharmacol Ther; 2014 Dec; 30(10):800-2. PubMed ID: 25244111
[TBL] [Abstract][Full Text] [Related]
6. [Surface activity and wetting action of preparations of artificial tears].
Chasovnikova LV; Formaziuk VE; Sergienko VI; Maĭchyk IuF
Biull Eksp Biol Med; 1993 Apr; 115(4):368-70. PubMed ID: 8049395
[TBL] [Abstract][Full Text] [Related]
7. Phosphate concentration in ophthalmic corticoid preparations.
Bernauer W; Thiel MA; Rentsch KM
Graefes Arch Clin Exp Ophthalmol; 2008 Jul; 246(7):975-8. PubMed ID: 18357463
[TBL] [Abstract][Full Text] [Related]
8. Corneal calcification following intensified treatment with sodium hyaluronate artificial tears.
Bernauer W; Thiel MA; Kurrer M; Heiligenhaus A; Rentsch KM; Schmitt A; Heinz C; Yanar A
Br J Ophthalmol; 2006 Mar; 90(3):285-8. PubMed ID: 16488945
[TBL] [Abstract][Full Text] [Related]
9. Allergic reactions to contact lens solutions.
Fisher AA
Cutis; 1985 Sep; 36(3):209-11. PubMed ID: 3931986
[No Abstract] [Full Text] [Related]
10. Relationship of eye burns with calcifications of the cornea?
Schrage NF; Kompa S; Ballmann B; Reim M; Langefeld S
Graefes Arch Clin Exp Ophthalmol; 2005 Aug; 243(8):780-4. PubMed ID: 15756579
[TBL] [Abstract][Full Text] [Related]
11. Changing the composition of buffered eye-drops prevents undesired side effects.
Schrage NF; Frentz M; Reim M
Br J Ophthalmol; 2010 Nov; 94(11):1519-22. PubMed ID: 20650912
[TBL] [Abstract][Full Text] [Related]
12. Letter: Corneal epithelial oedema.
Smith JH; Watkins R
Br J Ophthalmol; 1976 Jan; 60(1):75. PubMed ID: 1268166
[No Abstract] [Full Text] [Related]
13. Deep corneal calcification associated with preservative-free eyedrops and persistent epithelial defects.
Lake D; Tarn A; Ayliffe W
Cornea; 2008 Apr; 27(3):292-6. PubMed ID: 18362655
[TBL] [Abstract][Full Text] [Related]
14. [Drug-induced abnormalities of the cornea].
Ohashi Y
Nippon Ganka Gakkai Zasshi; 2001 Mar; 105(3):141-2. PubMed ID: 11280870
[No Abstract] [Full Text] [Related]
15. Tandem scanning confocal microscopic analysis of ciprofloxacin corneal deposits in vivo.
Essepian JP; Rajpal R; O'Brien TP
Cornea; 1995 Jul; 14(4):402-7. PubMed ID: 7671612
[No Abstract] [Full Text] [Related]
16. Calcific band keratopathy associated with the use of topical steroid-phosphate preparations.
Taravella MJ; Stulting RD; Mader TH; Weisenthal RW; Forstot SL; Underwood LD
Arch Ophthalmol; 1994 May; 112(5):608-13. PubMed ID: 8185516
[TBL] [Abstract][Full Text] [Related]
17. [Those "innocent" eyedrops].
Henkes HE; Waubke TN
Ned Tijdschr Geneeskd; 1978 Apr; 122(15):497-9. PubMed ID: 643103
[No Abstract] [Full Text] [Related]
18. Toxic keratopathy.
DeRosa AJ
Int Ophthalmol Clin; 1998; 38(4):15-22. PubMed ID: 10081722
[No Abstract] [Full Text] [Related]
19. Sparfloxacin corneal deposits.
Gokhale NS
Indian J Ophthalmol; 2004 Mar; 52(1):79. PubMed ID: 15132389
[No Abstract] [Full Text] [Related]
20. Phosphate and electrolyte content of topical steroid drops and potential clinical implications.
Mukherjee S; O'Reilly DS; Cox A; Ramaesh K
Br J Ophthalmol; 2008 Apr; 92(4):574-6. PubMed ID: 18369074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
